News
Dianthus Therapeutics targets severe autoimmune diseases with DNTH103. Read more on DNTH's promise amid competitive ...
Roivant Sciences secures $5.2B for advancing late-stage drugs like IMVT-1402 & brepocitinib. Click here to read an analysis ...
KORU Medical Systems, Inc.’s KRMD share price has surged by 7.49%, which has investors questioning if this is right time to ...
6d
Investor's Business Daily on MSNImmunovant Crumbles After Roivant Sweeps Out Its C-Suite, Unveils Strategic ShiftRoivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.
That means the future of Roivant is tied to the success, or otherwise, of Immunovant’s attempts to break into the FcRn market ...
6d
Asianet Newsable on MSNImmunovant Announces Roivant President Eric Venker As New CEO: Retail’s ElatedImmunovant stated that these changes are part of its parent entity, Roivant, increasing operational involvement and strategic ...
Ernesto Olvera, a Visalia resident, has been fighting a rare autoimmune disease known as chronic inflammatory demyelinating ...
who are anti-acetylcholine receptor antibody-positive and adult patients with chronic inflammatory demyelinating ...
In fact, research shows that eating foods containing anti-inflammatory properties, such as omega-3 fatty acids and richly pigmented fruits and vegetables, can help reduce markers of chronic ...
An expert has revealed six of the best anti-inflammatory foods to eat ... that have been associated with an increased risk for chronic diseases such as type 2 diabetes and heart disease are ...
antibody positive and adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP). VYVGART ® Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second ...
and specialising in the molecular mechanisms of chronic diseases like cancer and dementia, has now shared some easy and effective anti-inflammatory habits. From morning walks to a good diet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results